{
    "num_assign_task": 3,
    "num_acknowledge_contribution": 10,
    "num_encourage_participation": 9,
    "num_expand_on_existing_idea": 27,
    "num_propose_decision": 8,
    "num_provide_supporting_evidence": 10,
    "num_present_new_idea": 6,
    "num_express_agreement": 9,
    "num_explain_define_term": 9,
    "num_confirm_decision": 1,
    "num_offer_constructive_criticism": 1,
    "num_express_enthusiasm": 3,
    "num_express_frustration": 1,
    "num_express_humor": 2,
    "elaboration_to_idea_ratio": 4.5,
    "decision_closure_ratio": 0.125,
    "criticism_to_agreement_ratio": 0.1111111111111111,
    "num_resolve_conflict": 0,
    "num_reject_idea": 0,
    "net_positive_conflict_score": 0,
    "leadership_action_count": 21,
    "engagement_positivity_score": 14,
    "avg_speaking_duration": 22.3739837398374,
    "speaking_variance": 31.080906321861875,
    "speaking_time_ratio": {
        "Brenda Rubenstein": 0.058502906976744186,
        "Peter Dorhout": 0.08866279069767442,
        "Diego Huet": 0.06431686046511628,
        "Gisselle Medina": 0.13154069767441862,
        "William Witola": 0.19949127906976744,
        "Danae Schulz": 0.053052325581395346,
        "Erik Procko": 0.0650436046511628,
        "Wilfred van der Donk": 0.06686046511627906,
        "Angad Mehta": 0.15406976744186046,
        "Wilfred van der Donk UIUC/HHMI": 0.0403343023255814,
        "Arenas": 0.0690406976744186,
        "Richard Wiener": 0.009084302325581396
    },
    "participation_entropy": 5.980713394423056,
    "avg_nods_per_utterance": 0.21951219512195122,
    "avg_gestures_per_utterance": 0.0,
    "avg_eye_contact_per_utterance": 0.0,
    "avg_distraction_per_utterance": 0.008130081300813009,
    "avg_confusion_per_utterance": 0.0,
    "avg_engagement_per_utterance": 0.0,
    "gesture_type_distribution": {
        "Open Palms": 16,
        "Pointing": 3,
        "Raising Hand": 3,
        "Thumbs up": 1
    },
    "gesture_variety": {
        "Brenda Rubenstein": 1,
        "Diego Huet": 1,
        "Danae Schulz": 1,
        "Angad Mehta": 2,
        "William Witola": 1,
        "Arenas": 1,
        "Gisselle Medina": 1,
        "Peter Dorhout": 1,
        "Wilfred van der Donk UIUC/HHMI": 1
    },
    "gesture_count_ratio": 0.18699186991869918,
    "num_interruptions": 0,
    "num_overlaps": 2,
    "interruption_rate_by_speaker": {},
    "interruption_received": {},
    "screenshare_count": 5,
    "screenshare_duration": 467.0,
    "avg_screenshare_segment_length": 93.4,
    "screenshare_content": [
        "The screen shows a headshot of William Witola.",
        "The screen shows a headshot of William Witola.",
        "A photo of William Witola is displayed on the screen. The photo remains unchanged throughout the segment.",
        "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The current slide is titled \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The slide lists several bullet points related to therapeutic and inhibitory strategies, including using platforms for screening small molecule scaffolds, RNA therapeutics, target pathogen entry blocking receptors, CRISPR-based strategies, transcriptomics profiling, and inhibitors for essential enzymes. A list of participants is on the right side of the slide.",
        "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The current slide is titled \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The slide lists several bullet points related to therapeutic and inhibitory strategies, including using platforms for screening small molecule scaffolds, RNA therapeutics, target pathogen entry blocking receptors, CRISPR-based strategies, transcriptomics profiling, and inhibitors for essential enzymes. A list of participants is on the right side of the slide.",
        "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The current slide is titled \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The slide lists several bullet points related to therapeutic and inhibitory strategies, including using platforms for screening small molecule scaffolds, RNA therapeutics, target pathogen entry blocking receptors, CRISPR-based strategies, transcriptomics profiling, and inhibitors for essential enzymes. A list of participants is on the right side of the slide.",
        "The screen shows a Google Slides presentation titled \"Scaling MZT Meeting Slides\". The slide displayed is \"Room 1.3 - Key points: Therapeutics and Inhibitors\", which lists various strategies for developing bioactives. The presenter is not actively changing the content.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach.",
        "The screen is being shared and displays a Google Docs document titled \"Scaling MZT Meeting Slides\". The document contains a list of key points under the heading \"Room 1.3 - Key points: Therapeutics and Inhibitors\". The list includes items such as using high-throughput platforms for screening small molecule scaffolds and targeted delivery of small molecules/peptides to intracellular pathogens and viruses - nanoparticle based approach."
    ],
    "screenshare_decision_overlap": 0.09090909090909091,
    "ideas_first_half": 1,
    "ideas_second_half": 5,
    "decision_lag": 90.5,
    "idea_agree_decision_chain_duration": 30.0,
    "burstiness_of_ideas": 1.0897247358851685
}